L'essentiel de la génétique, édition De Boeck, 2012. ,
Gene-Environment Interactions in Cancer Epidemiology: A National Cancer Institute Think Tank Report, Genetic Epidemiology, vol.27, issue.15, pp.643-657, 2013. ,
DOI : 10.1002/gepi.21756
[Hereditary predispositions to gynaecological cancers ,
Pr??dispositions g??n??tiques aux cancers??: actualit??s et perspectives en 2010, Pathologie Biologie, vol.58, issue.5, pp.324-330, 2010. ,
DOI : 10.1016/j.patbio.2010.02.004
Clinical and molecular diagnosis of inherited breast-ovarian cancer], J Gynécologie Obstétrique Biol Reprod. avr, vol.32, issue.2, pp.101-119, 2003. ,
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13, Science, vol.265, issue.5181, pp.2088-2090, 1994. ,
DOI : 10.1126/science.8091231
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q, Nature Genetics, vol.1, issue.1, pp.103-107, 1994. ,
DOI : 10.1038/ng1093-109
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, vol.266, issue.5182 ,
DOI : 10.1126/science.7545954
BRCA1 and BRCA2 and the genetics of breast and ovarian [Identification and management of hereditary breast-ovarian cancers, 2004. ,
Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study, Journal of Clinical Oncology, vol.26, issue.8, pp.1331-1337, 2008. ,
DOI : 10.1200/JCO.2007.13.9626
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies, The American Journal of Human Genetics, vol.72, issue.5, pp.1117-1130, 2003. ,
DOI : 10.1086/375033
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE, JNCI Journal of the National Cancer Institute, vol.105, issue.11, pp.812-822, 2013. ,
DOI : 10.1093/jnci/djt095
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers, British Journal of Cancer, vol.351, issue.9, pp.1384-1392, 2011. ,
DOI : 10.1038/bjc.2011.120
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer ,
Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families, Cancer Res. 1 août, vol.57, issue.15, pp.3245-3252, 1997. ,
Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA, édition Routledge, 2014. ,
Opinion: Hallmarks of 'BRCAness' in sporadic cancers, Nature Reviews Cancer, vol.56, issue.10, pp.814-819, 2004. ,
DOI : 10.1093/jnci/90.15.1138
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers, British Journal of Cancer, vol.54, issue.12, pp.2005-2009, 2012. ,
DOI : 10.1200/JCO.2011.39.5590
The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study, Gynecologic Oncology, vol.104, issue.1, pp.7-10, 2007. ,
DOI : 10.1016/j.ygyno.2006.08.004
BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews, Clinical Cancer Research, vol.10, issue.9, pp.2918-2921, 2004. ,
DOI : 10.1158/1078-0432.CCR-03-0604
The genetic epidemiology of BRCA1, The Lancet, vol.344, issue.8924, p.761, 1994. ,
DOI : 10.1016/S0140-6736(94)92256-X
Ovarian carcinogenesis: recent and past hypotheses]. Gynécologie Obstétrique Fertil, avr, vol.39, issue.4, pp.216-223, 2011. ,
has-sante.fr/portail/jcms/c_1050648/fr/depistage-du- cancer-du-sein-en-france-identification-des-femmes-a-haut-risque-et-modalites-de- depistage-note-de-cadrage?xtmc=&xtcr=9 ,
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee, Annals of Oncology, vol.9, issue.9, pp.939-950, 1998. ,
DOI : 10.1023/A:1008389021382
principales-recommandations-de-prise-en-charge-des-femmes-porteuses- dune-mutation-de-brca1-ou-brca2, Cancer Res BCR, vol.6, issue.1, pp.8-17, 2004. ,
The pathology of familial breast cancer: Immunohistochemistry and molecular analysis, Breast Cancer Research, vol.34, issue.1, pp.36-40, 1999. ,
DOI : 10.1046/j.1365-2559.1999.00548.x
Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers, Clinical Cancer Research, vol.10, issue.7, pp.2473-2481, 2004. ,
DOI : 10.1158/1078-0432.CCR-1029-3
Association Between <emph type="ital">BRCA1</emph> and <emph type="ital">BRCA2</emph> Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer, JAMA, vol.307, issue.4, pp.382-390, 2012. ,
DOI : 10.1001/jama.2012.20
Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, the French National BRCA1/2 carrier cohort (GENEPSO) ,
URL : https://hal.archives-ouvertes.fr/hal-00698006
Mutation Carriers: The PROSE Study Group, Journal of Clinical Oncology, vol.23, issue.31, pp.7804-7810, 2005. ,
DOI : 10.1200/JCO.2004.00.8151
Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1 ,
Age at menarche and menopause and breast cancer risk in the International BRCA1 ,
Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol, avr, vol.16, issue.4, pp.740-746, 2007. ,
The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation, Breast Cancer Research and Treatment, vol.38, issue.1, pp.177-185, 2013. ,
DOI : 10.1007/s10549-013-2729-1
Role of Breast Surgery in BRCA Mutation Carriers, Breast Care, vol.7, issue.5, pp.378-382, 2012. ,
DOI : 10.1159/000343717
Breast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer?, Annals of Surgical Oncology, vol.286, issue.18, pp.3380-3387, 2009. ,
DOI : 10.1245/s10434-009-0638-7
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status, The Lancet, vol.359, issue.9316, pp.1471-1477, 2002. ,
DOI : 10.1016/S0140-6736(02)08434-9
Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ???40??years, Breast Cancer Research and Treatment, vol.353, issue.16, pp.207-215, 2011. ,
DOI : 10.1007/s10549-010-1110-x
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis, Breast Cancer Research and Treatment, vol.101, issue.15 suppl, pp.443-455, 2014. ,
DOI : 10.1007/s10549-014-2890-1
Drug therapy for hereditary cancers, Hereditary Cancer in Clinical Practice, vol.19, issue.Suppl 1, p.5, 2011. ,
DOI : 10.1111/IGC.0b013e3181bb703f
Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status, JNCI Journal of the National Cancer Institute, vol.94, issue.19, pp.1504-1506, 2002. ,
DOI : 10.1093/jnci/94.19.1504-a
Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed?, European Journal of Cancer, vol.48, issue.13, pp.1939-1946, 1990. ,
DOI : 10.1016/j.ejca.2012.03.004
Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time, Annals of Oncology, vol.23, issue.4, pp.882-890, 2012. ,
DOI : 10.1093/annonc/mdr330
Preventive therapy for breast cancer: a consensus statement, The Lancet Oncology, vol.12, issue.5, pp.496-503, 2011. ,
DOI : 10.1016/S1470-2045(11)70030-4
Mutation Carriers, New England Journal of Medicine, vol.361, issue.2, pp.123-134, 2009. ,
DOI : 10.1056/NEJMoa0900212
Hereditary ovarian cancer, Human Pathology, vol.36, issue.8, pp.861-870, 2005. ,
DOI : 10.1016/j.humpath.2005.06.006
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial, The Lancet, vol.376, issue.9737, pp.235-244, 2010. ,
DOI : 10.1016/S0140-6736(10)60892-6
recommandations-de-pratique-clinique/586-chirurgie-prophylactique-dans-les- cancers-avec-predisposition-genetique ,
Impact of family history on BRCA2 carriers, Microsurgery. mai, vol.34, issue.4, pp.271-276, 2014. ,
The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation, Psycho-Oncology, vol.39, issue.2, pp.212-219, 2013. ,
DOI : 10.1002/pon.2041
The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation, Gynecologic Oncology, vol.121, issue.1, pp.163-168, 2011. ,
DOI : 10.1016/j.ygyno.2010.12.326
LHRH agonists and the prevention of breast and ovarian cancer, British Journal of Cancer, vol.60, issue.1, pp.142-148, 1989. ,
DOI : 10.1038/bjc.1989.237
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial, On behalf the French Federation of Cancer Centres Pujol, pp.77-84, 2012. ,
Surveillance of <EMPH TYPE="ITAL">BRCA1</EMPH> and <EMPH TYPE="ITAL">BRCA2</EMPH> Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination, JAMA, vol.292, issue.11, pp.1317-1325, 2004. ,
DOI : 10.1001/jama.292.11.1317
Mammographic, US, and MR Imaging Phenotypes of Familial Breast Cancer, Radiology, vol.246, issue.1, pp.58-70, 2008. ,
DOI : 10.1148/radiol.2461062173
Estimated Risk of Radiation-Induced Breast Cancer From Mammographic Screening for Young BRCA Mutation Carriers, JNCI Journal of the National Cancer Institute, vol.101, issue.3, pp.205-209, 2009. ,
DOI : 10.1093/jnci/djn440
30 -Cancer du sein Disponible sur, 2010. ,
30 -Cancer de l'ovaire [Internet] Disponible sur, 2010. ,
Genetic testing for familial cancer. The French National Report (year 2003), Community Genet, vol.11, issue.1, pp.63-67, 2008. ,
Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing, European Journal of Cancer, vol.42, issue.7, pp.871-881, 1990. ,
DOI : 10.1016/j.ejca.2005.10.029
URL : https://hal.archives-ouvertes.fr/hal-00428000
It???s not for me??? It???s for my daughter, European Journal of Cancer, vol.43, issue.2, pp.226-227, 1990. ,
DOI : 10.1016/j.ejca.2006.08.027
Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress, Patient Education and Counseling, vol.65, issue.1 ,
DOI : 10.1016/j.pec.2006.05.006
Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study, Clinical Genetics, vol.13, issue.2, pp.35-42, 2007. ,
DOI : 10.1111/j.1399-0004.2007.00731.x
Effects of genetic consultation on perception of a family risk of breast/ovarian cancer and determinants of inaccurate perception after the consultation, Journal of Clinical Epidemiology, vol.55, issue.7, pp.665-675, 2002. ,
DOI : 10.1016/S0895-4356(02)00401-8
Mutations at the Time of Diagnosis?, Journal of Clinical Oncology, vol.30, issue.1, pp.2-3, 2012. ,
DOI : 10.1200/JCO.2011.37.6509
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers, Human Genetics, vol.38, issue.5, pp.685-699, 2011. ,
DOI : 10.1007/s00439-011-1003-z
URL : https://hal.archives-ouvertes.fr/hal-00837832
Population-Based Study of Changing Breast Cancer Risk in Icelandic BRCA2 Mutation Carriers, 1920-2000, JNCI Journal of the National Cancer Institute, vol.98, issue.2, pp.116-122, 2006. ,
DOI : 10.1093/jnci/djj012
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas, Breast Cancer Research and Treatment, vol.103, issue.3, pp.591-596, 2011. ,
DOI : 10.1007/s10549-010-1156-9
La population réunionnaise : Analyse démographique, édition 82 IRD, 2007. ,
DOI : 10.4000/books.irdeditions.105
Le cancer du sein chez la femme de moins de 50 ans à la Réunion entre, 2005. ,
Epidémiologie des cancers gynécologiques, 2013. ,
Disponible sur: http://kach0k, 2008. ,
Aux origines de l'identité réunionnaise, éditions L'Hamarttan, 1993. ,
Inter- and Extra-Indian Admixture and Genetic Diversity in Reunion Island Revealed by Analysis of Mitochondrial DNA, Annals of Human Genetics, vol.70, issue.3, pp.314-334, 2009. ,
DOI : 10.1111/j.1469-1809.2009.00519.x
URL : https://hal.archives-ouvertes.fr/halshs-00433392
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO), Breast Cancer Research, vol.70, issue.4, p.99, 2012. ,
DOI : 10.1158/0008-5472.CAN-09-3460
Les cancers en France, 2013. ,
Dépistage organisé du cancer du sein en France : pour une optimisation de l'information. Rev DÉpidémiologie Santé Publique, avr, vol.62, issue.2, pp.109-117, 2014. ,
Synthèse activité oncogénétique 2012 et consultations laboratoires 2014, 2014. ,